Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

Originally published as JCO Early Release 10.1200/JCO.2005.08.001 on September 12 2005

Journal of Clinical Oncology, Vol 23, No 30 (October 20), 2005: pp. 7703-7720
© 2005 American Society of Clinical Oncology.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lyman, G. H.
Right arrow Articles by Winer, E. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lyman, G. H.
Right arrow Articles by Winer, E. P.

ASCO SPECIAL ARTICLE

American Society of Clinical Oncology Guideline Recommendations for Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer

Gary H. Lyman, Armando E. Giuliano, Mark R. Somerfield, Al B. Benson, III, Diane C. Bodurka, Harold J. Burstein, Alistair J. Cochran, Hiram S. Cody, III, Stephen B. Edge, Sharon Galper, James A. Hayman, Theodore Y. Kim, Cheryl L. Perkins, Donald A. Podoloff, Visa Haran Sivasubramaniam, Roderick R. Turner, Richard Wahl, Donald L. Weaver, Antonio C. Wolff, Eric P. Winer

From the University of Rochester School of Medicine and Dentistry, Rochester, NY; John Wayne Cancer Institute, Santa Monica, CA; Northwestern University, Evanston, IL; The University of Texas M.D. Anderson Cancer Center, Houston, TX; Dana-Farber Cancer Institute, Boston, MA; David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA; Memorial Sloan-Kettering Cancer Center, New York, NY; Roswell Park Cancer Institute, Buffalo, NY; Brigham and Women's Hospital, Boston, MA; University of Michigan, Ann Arbor, MI; Tufts-New England Medical Center, Boston, MA; the Susan G. Komen Breast Cancer Foundation, Dallas, TX; The University of Texas M.D. Anderson Cancer Center, Houston, TX; University of Kentucky, Lexington, KY; St John's Health Center, Santa Monica, CA; The Johns Hopkins University, Baltimore, MD; University of Vermont College of Medicine, Burlington, VT; Dana-Farber Cancer Institute, Boston, MA; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD

PURPOSE: To develop a guideline for the use of sentinel node biopsy (SNB) in early stage breast cancer.

METHODS: An American Society of Clinical Oncology (ASCO) Expert Panel conducted a systematic review of the literature available through February 2004 on the use of SNB in early-stage breast cancer. The panel developed a guideline for clinicians and patients regarding the appropriate use of a sentinel lymph node identification and sampling procedure from hereon referred to as SNB. The guideline was reviewed by selected experts in the field and the ASCO Health Services Committee and was approved by the ASCO Board of Directors.

RESULTS: The literature review identified one published prospective randomized controlled trial in which SNB was compared with axillary lymph node dissection (ALND), four limited meta-analyses, and 69 published single-institution and multicenter trials in which the test performance of SNB was evaluated with respect to the results of ALND (completion axillary dissection). There are currently no data on the effect of SLN biopsy on long-term survival of patients with breast cancer. However, a review of the available evidence demonstrates that, when performed by experienced clinicians, SNB appears to be a safe and acceptably accurate method for identifying early-stage breast cancer without involvement of the axillary lymph nodes.

CONCLUSION: SNB is an appropriate initial alternative to routine staging ALND for patients with early-stage breast cancer with clinically negative axillary nodes. Completion ALND remains standard treatment for patients with axillary metastases identified on SNB. Appropriately identified patients with negative results of SNB, when done under the direction of an experienced surgeon, need not have completion ALND. Isolated cancer cells detected by pathologic examination of the SLN with use of specialized techniques are currently of unknown clinical significance. Although such specialized techniques are often used, they are not a required part of SLN evaluation for breast cancer at this time. Data suggest that SNB is associated with less morbidity than ALND, but the comparative effects of these two approaches on tumor recurrence or patient survival are unknown.

Authors' disclosures of potential conflicts of interest are found at the end of this article.

Address reprint requests to American Society of Clinical Oncology, Cancer Policy and Clinical Affairs, 1900 Duke St, Suite 200, Alexandria, VA 22314; e-mail: guidelines@asco.org.




This article has been cited by other articles:


Home page
Ann. Surg. Oncol.Home page
E. Poirier, L. Sideris, P. Dube, P. Drolet, and S. H. Meterissian
Analysis of Clinical Applicability of the Breast Cancer Nomogram for Positive Sentinel Lymph Node: The Canadian Experience
Ann. Surg. Oncol., September 1, 2008; 15(9): 2562 - 2567.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Radiol.Home page
E L SENIOR, R SINNATAMBY, and R EATON
The chest X-ray black hole
Br. J. Radiol., August 1, 2008; 81(968): 677 - 678.
[Full Text] [PDF]


Home page
JCOHome page
H. D. Bear
Completion Axillary Lymph Node Dissection for Breast Cancer: Immediate Versus Delayed Versus None
J. Clin. Oncol., July 20, 2008; 26(21): 3483 - 3484.
[Full Text] [PDF]


Home page
JCOHome page
J. A. Olson Jr, L. M. McCall, P. Beitsch, P. W. Whitworth, D. S. Reintgen, P. W. Blumencranz, A. M. Leitch, S. Saha, K. K. Hunt, and A. E. Giuliano
Impact of Immediate Versus Delayed Axillary Node Dissection on Surgical Outcomes in Breast Cancer Patients With Positive Sentinel Nodes: Results From American College of Surgeons Oncology Group Trials Z0010 and Z0011
J. Clin. Oncol., July 20, 2008; 26(21): 3530 - 3535.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
R. Crane-Okada, R. A. Wascher, D. Elashoff, and A. E. Giuliano
Long-Term Morbidity of Sentinel Node Biopsy Versus Complete Axillary Dissection for Unilateral Breast Cancer
Ann. Surg. Oncol., July 1, 2008; 15(7): 1996 - 2005.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
K. A. Vanderveen, R. Ramsamooj, and R. J. Bold
A Prospective, Blinded Trial of Touch Prep Analysis versus Frozen Section for Intraoperative Evaluation of Sentinel Lymph Nodes in Breast Cancer
Ann. Surg. Oncol., July 1, 2008; 15(7): 2006 - 2011.
[Abstract] [Full Text] [PDF]


Home page
Arch SurgHome page
B. J. Grube, C. J. Christy, D. Black, M. Martel, L. Harris, J. Weidhaas, M. P. DiGiovanna, G. Chung, M. M. Abu-Khalaf, K. D. Miller, et al.
Breast Sentinel Lymph Node Dissection Before Preoperative Chemotherapy
Arch Surg, July 1, 2008; 143(7): 692 - 700.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
C. E. Cox, J. M. Cox, D. Ramos, and T. L. Meade
Intramammary Sentinel Lymph Nodes: What is the Clinical Significance?
Ann. Surg. Oncol., May 1, 2008; 15(5): 1273 - 1274.
[Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
S. Samphao, J. M. Eremin, M. El-Sheemy, and O. Eremin
Management of the Axilla in Women With Breast Cancer: Current Clinical Practice and a New Selective Targeted Approach
Ann. Surg. Oncol., May 1, 2008; 15(5): 1282 - 1296.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
M. Intra, C. A. Garcia-Etienne, G. Renne, G. Trifiro, N. Rotmensz, O. D. Gentilini, V. Galimberti, A. Sagona, D. Mattar, C. Sangalli, et al.
When Sentinel Lymph Node is Intramammary
Ann. Surg. Oncol., May 1, 2008; 15(5): 1304 - 1308.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
P. Gimbergues, C. Abrial, X. Durando, G. Le Bouedec, F. Cachin, F. Penault-Llorca, M. A. Mouret-Reynier, F. Kwiatkowski, J. Maublant, A. Tchirkov, et al.
Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy Is Accurate in Breast Cancer Patients with a Clinically Negative Axillary Nodal Status at Presentation
Ann. Surg. Oncol., May 1, 2008; 15(5): 1316 - 1321.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
K. Dahl, M. Karlsson, P. Marits, A. Hoffstedt, O. Winqvist, and M. Thorn
Metinel Node--The First Lymph Node Draining a Metastasis--Contains Tumor-Reactive Lymphocytes
Ann. Surg. Oncol., May 1, 2008; 15(5): 1454 - 1463.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
A. Y. Chen, M. T. Halpern, N. M. Schrag, A. Stewart, M. Leitch, and E. Ward
Disparities and Trends in Sentinel Lymph Node Biopsy Among Early-Stage Breast Cancer Patients (1998-2005)
J Natl Cancer Inst, April 2, 2008; 100(7): 462 - 474.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
S. B. Edge
Early Adoption and Disturbing Disparities in Sentinel Node Biopsy in Breast Cancer
J Natl Cancer Inst, April 2, 2008; 100(7): 449 - 450.
[Full Text] [PDF]


Home page
CMAJHome page
T. J. Selman, C. Mann MD, J. Zamora PhD, T.-L. Appleyard MBBS, and K. Khan MSc
Diagnostic accuracy of tests for lymph node status in primary cervical cancer: a systematic review and meta-analysis
Can. Med. Assoc. J., March 25, 2008; 178(7): 855 - 862.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
A. M. Fink, H. Lass, H. Hartleb, W. Jurecka, H. Salzer, and A. Steiner
S-Classification of Sentinel Lymph Node Predicts Axillary Nonsentinel Lymph Node Status in Patients with Breast Cancer
Ann. Surg. Oncol., March 1, 2008; 15(3): 848 - 853.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
E. J.T. Rutgers
Sentinel Node Biopsy: Interpretation and Management of Patients With Immunohistochemistry-Positive Sentinel Nodes and Those With Micrometastases
J. Clin. Oncol., February 10, 2008; 26(5): 698 - 702.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
N. C. Hodgson and K. Y. Gulenchyn
Is There a Role for Positron Emission Tomography in Breast Cancer Staging?
J. Clin. Oncol., February 10, 2008; 26(5): 712 - 720.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
N. Duraker, Z. C. Caynak, and B. Bati
Is there any Prognostically Different Subgroup among Patients with Stage IIIC (AnyTN3M0) Breast Carcinoma?
Ann. Surg. Oncol., February 1, 2008; 15(2): 430 - 437.
[Abstract] [Full Text] [PDF]


Home page
Br Med BullHome page
S. K. Somasundaram, D. W. Chicken, and M. R. S. Keshtgar
Detection of the sentinel lymph node in breast cancer
Br. Med. Bull., January 3, 2008; (2008) ldm032v1.
[Abstract] [Full Text] [PDF]


Home page
radtechHome page
J. MINIGH
Sentinel Lymph Node Mapping of the Breast
Radiol. Technol., January 1, 2008; 79(3): 243M - 257M.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
M. Kaufmann, G. von Minckwitz, H. D. Bear, A. Buzdar, P. McGale, H. Bonnefoi, M. Colleoni, C. Denkert, W. Eiermann, R. Jackesz, et al.
Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: new perspectives 2006
Ann. Onc., December 1, 2007; 18(12): 1927 - 1934.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
Y. Delpech, A. Cortez, C. Coutant, P. Callard, S. Uzan, E. Darai, and E. Barranger
The sentinel node concept in endometrial cancer: histopathologic validation by serial section and immunohistochemistry
Ann. Onc., November 1, 2007; 18(11): 1799 - 1803.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
E. A. Newman, M. S. Sabel, A. V. Nees, A. Schott, K. M. Diehl, V. M. Cimmino, A. E. Chang, C. Kleer, D. F. Hayes, and L. A. Newman
Sentinel Lymph Node Biopsy Performed After Neoadjuvant Chemotherapy is Accurate in Patients with Documented Node-Positive Breast Cancer at Presentation
Ann. Surg. Oncol., October 1, 2007; 14(10): 2946 - 2952.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
C. K. Kuhl
Current Status of Breast MR Imaging * Part 2. Clinical Applications
Radiology, September 1, 2007; 244(3): 672 - 691.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. Tsujimoto, K. Nakabayashi, K. Yoshidome, T. Kaneko, T. Iwase, F. Akiyama, Y. Kato, H. Tsuda, S. Ueda, K. Sato, et al.
One-step Nucleic Acid Amplification for Intraoperative Detection of Lymph Node Metastasis in Breast Cancer Patients
Clin. Cancer Res., August 15, 2007; 13(16): 4807 - 4816.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
T. B. Julian, S. R. Land, V. Fourchotte, S. R. Haile, E. R. Fisher, E. P. Mamounas, J. P. Costantino, and N. Wolmark
Is Sentinel Node Biopsy Necessary in Conservatively Treated DCIS?
Ann. Surg. Oncol., August 1, 2007; 14(8): 2202 - 2208.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
E. R. Port, C. A. Garcia-Etienne, J. Park, J. Fey, P. I. Borgen, and H. S. Cody III
Reoperative Sentinel Lymph Node Biopsy: A New Frontier in the Management of Ipsilateral Breast Tumor Recurrence
Ann. Surg. Oncol., August 1, 2007; 14(8): 2209 - 2214.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
D. P. Cronin-Fenton, L. A. Ries, L. X. Clegg, and B. K. Edwards
Rising Incidence Rates of Breast Carcinoma With Micrometastatic Lymph Node Involvement
J Natl Cancer Inst, July 4, 2007; 99(13): 1044 - 1049.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
C. D. Shriver
How Does It Feel? Sentinel Node Biopsy Is Better
Ann. Surg. Oncol., May 1, 2007; 14(5): 1530 - 1531.
[Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
K. A. Vanderveen, D. A. Paterniti, R. L. Kravitz, and R. J. Bold
Diffusion of Surgical Techniques in Early Stage Breast Cancer: Variables Related to Adoption and Implementation of Sentinel Lymph Node Biopsy
Ann. Surg. Oncol., May 1, 2007; 14(5): 1662 - 1669.
[Abstract] [Full Text] [PDF]


Home page
Arch SurgHome page
A. B. Chagpar, C. R. Scoggins, R. C. G. Martin II, D. J. Carlson, A. L. Laidley, S. E. El-Eid, T. Q. McGlothin, K. M. McMasters, and for the University of Louisville Breast Sentinel L
Are 3 Sentinel Nodes Sufficient?
Arch Surg, May 1, 2007; 142(5): 456 - 460.
[Abstract] [Full Text] [PDF]


Home page
The OncologistHome page
O. Gentilini, E. Chagas, S. Zurrida, M. Intra, C. De Cicco, G. Gatti, L. Silva, G. Renne, E. Cassano, and U. Veronesi
Sentinel Lymph Node Biopsy in Male Patients with Early Breast Cancer
Oncologist, May 1, 2007; 12(5): 512 - 515.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
C. Mathelin, S. Salvador, D. Huss, and J.-L. Guyonnet
Precise Localization of Sentinel Lymph Nodes and Estimation of Their Depth Using a Prototype Intraoperative Mini {gamma}-Camera in Patients with Breast Cancer
J. Nucl. Med., April 1, 2007; 48(4): 623 - 629.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
M. S. Pugliese, R. Tickman, N. P. Wang, M. Atwood, and J D. Beatty
The Utility of Intraoperative Evaluation of Sentinel Lymph Nodes in Breast Cancer
Ann. Surg. Oncol., March 1, 2007; 14(3): 1024 - 1030.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
A. Soran, J. Falk, M. Bonaventura, D. Keenan, G. Ahrendt, and R. Johnson
Is Routine Sentinel Lymph Node Biopsy Indicated in Women Undergoing Contralateral Prophylactic Mastectomy? Magee-Womens Hospital Experience
Ann. Surg. Oncol., February 1, 2007; 14(2): 646 - 651.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
M. M. Mondi, R. E. Cuenca, D. W. Ollila, J. H. Stewart IV, and E. A. Levine
Sentinel Lymph Node Biopsy During Pregnancy: Initial Clinical Experience
Ann. Surg. Oncol., January 1, 2007; 14(1): 218 - 221.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
C. M. Balch and N. Cascinelli
Sentinel-Node Biopsy in Melanoma
N. Engl. J. Med., September 28, 2006; 355(13): 1370 - 1371.
[Full Text] [PDF]


Home page
JCOHome page
S. M. Enger, S. S. Thwin, D. S.M. Buist, T. Field, F. Frost, A. M. Geiger, T. L. Lash, M. Prout, M. U. Yood, F. Wei, et al.
Breast Cancer Treatment of Older Women in Integrated Health Care Settings
J. Clin. Oncol., September 20, 2006; 24(27): 4377 - 4383.
[Abstract] [Full Text] [PDF]


Home page
J. Nucl. Med. Technol.Home page
D. R. Smyth
Rapid Determination of the Radiochemical Purity of 99mTc-Antimony Trisulfide Colloid Prepared by Standard and Alternative Heating Methods.
J. Nucl. Med. Technol., September 1, 2006; 34(3): 174 - 178.
[Abstract] [Full Text] [PDF]


Home page
CA Cancer J ClinHome page
S. L. Chen, D. M. Iddings, R. P. Scheri, and A. J. Bilchik
Lymphatic Mapping and Sentinel Node Analysis: Current Concepts and Applications
CA Cancer J Clin, September 1, 2006; 56(5): 292 - 309.
[Abstract] [Full Text] [PDF]


Home page
Arch SurgHome page
A. Chung, D. Liou, S. Karlan, A. Waxman, K. Fujimoto, M. Hagiike, and E. H. Phillips
Preoperative FDG-PET for Axillary Metastases in Patients With Breast Cancer
Arch Surg, August 1, 2006; 141(8): 783 - 789.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
M. Knauer, P. Konstantiniuk, A. Haid, E. Wenzl, M. Riegler-Keil, S. Postlberger, R. Reitsamer, and P. Schrenk
Multicentric Breast Cancer: A New Indication for Sentinel Node Biopsy--A Multi-Institutional Validation Study
J. Clin. Oncol., July 20, 2006; 24(21): 3374 - 3380.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
J. Pater and W. Parulekar
Sentinel lymph node biopsy in early breast cancer: has its time come?
J Natl Cancer Inst, May 3, 2006; 98(9): 568 - 569.
[Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
R. E. Mansel, L. Fallowfield, M. Kissin, A. Goyal, R. G. Newcombe, J. M. Dixon, C. Yiangou, K. Horgan, N. Bundred, I. Monypenny, et al.
Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial.
J Natl Cancer Inst, May 3, 2006; 98(9): 599 - 609.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
B. A. Carter and D. L. Page
Sentinel Lymph Node Histopathology in Breast Cancer: Minimal Disease Versus Artifact
J. Clin. Oncol., May 1, 2006; 24(13): 1978 - 1979.
[Full Text] [PDF]


Home page
JCOHome page
H. D. Bear
Sentinel Node Micrometastases and Non-Sentinel Nodes in Breast Cancer: How Much Do We Need to Know?
J. Clin. Oncol., April 20, 2006; 24(12): 1788 - 1790.
[Full Text] [PDF]


Home page
BMJHome page
A. Hemminki and P.-L. Kellokumpu-Lehtinen
Harmful impact of EU clinical trials directive.
BMJ, March 4, 2006; 332(7540): 501 - 502.
[Full Text] [PDF]


Home page
JCOHome page
V. Galimberti
International Breast Cancer Study Group Trial of Sentinel Node Biopsy
J. Clin. Oncol., January 1, 2006; 24(1): 210 - 211.
[Full Text] [PDF]



About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 2005 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online